237 related articles for article (PubMed ID: 17262739)
1. Peritoneum as the first-line of defense in carcinomatosis.
Sugarbaker PH
J Surg Oncol; 2007 Feb; 95(2):93-6. PubMed ID: 17262739
[No Abstract] [Full Text] [Related]
2. [how I do the resection of the diaphragmatic peritoneum in ovarian carcinomatosis].
Leblanc E
Gynecol Obstet Fertil; 2004 Apr; 32(4):345-6. PubMed ID: 15123107
[No Abstract] [Full Text] [Related]
3. A curative approach to peritoneal carcinomatosis from colorectal cancer.
Sugarbaker PH
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S68-73. PubMed ID: 16399436
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach.
Sugarbaker PH
Expert Opin Pharmacother; 2009 Aug; 10(12):1965-77. PubMed ID: 19563273
[TBL] [Abstract][Full Text] [Related]
5. [Evolution and perspectives in the surgical treatment of ovarian cancer].
Cherenkov VG; Shpenkova AA
Vopr Onkol; 2010; 56(4):450-5. PubMed ID: 20968025
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed...
Lambert LA; Mansfield PF
Ann Surg Oncol; 2007 Nov; 14(11):3037-9. PubMed ID: 17726635
[No Abstract] [Full Text] [Related]
7. An evolving role of perioperative intraperitoneal chemotherapy after cytoreductive surgery for colorectal peritoneal carcinomatosis.
Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Jul; 14(7):2171-2. PubMed ID: 17453299
[No Abstract] [Full Text] [Related]
8. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
[TBL] [Abstract][Full Text] [Related]
10. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Iversen LH; Rasmussen PC; Laurberg S
Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
[TBL] [Abstract][Full Text] [Related]
11. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
[TBL] [Abstract][Full Text] [Related]
12. Circulating CA125 and diffuse malignant peritoneal mesothelioma.
Baratti D; Kusamura S; Deraco M
Eur J Surg Oncol; 2009 Nov; 35(11):1198-9. PubMed ID: 19423265
[No Abstract] [Full Text] [Related]
13. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
14. Lessons learnt from clinical trials in peritoneal surface oncology: colorectal carcinomatosis.
Zoetmulder FA; Verwaal VJ
Recent Results Cancer Res; 2007; 169():99-103. PubMed ID: 17506253
[No Abstract] [Full Text] [Related]
15. [Cytoreductive surgery and intraperitoneal chemotherapy in colorectal cancer].
Fischer A
Ugeskr Laeger; 2007 Sep; 169(38):3177. PubMed ID: 17910823
[No Abstract] [Full Text] [Related]
16. [Mesothelioma of the peritoneum].
Jacyna-Onyszkiewicz T; Panecka A
Pol Przegl Chir; 1971 May; 43(5):737-40. PubMed ID: 5091785
[No Abstract] [Full Text] [Related]
17. Review of a personal experience in the management of carcinomatosis and sarcomatosis.
Sugarbaker PH
Jpn J Clin Oncol; 2001 Dec; 31(12):573-83. PubMed ID: 11902487
[TBL] [Abstract][Full Text] [Related]
18. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Bijelic L; Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
20. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
